FDA's Morning-After Pill Shift Stirs Debate

For Susan Wood, Wednesday's announcement by the U.S. Food and Drug Administration may have offered a degree of vindication that has been nearly four years in the making. In August 2005, Wood -- formerly the assistant FDA commissioner for women's health and director of the Office of Women's Health -- resigned from her post over a decision by the agency to further delay over-the-counter access to the Plan B contraceptive, also known as the morning after pill. One year later, the FDA approved the...Full Story
Commenting on this article is closed.